Parexel Appoints Peyton Howell as Chief Executive Officer (CEO) to Succeed Jamie Macdonald
Position
Chief Executive Officer
Company
Parexel
DurhamBiotechnologyHealth CareMedicalTherapeuticsDescription
Parexel announced that Chief Operating and Growth Officer Peyton Howell will succeed Jamie Macdonald as Chief Executive Officer (CEO) effective May 15, 2024, while also being appointed to the company’s Board of Directors on the same date. Jamie Macdonald will continue on the Board through Dec. 31, 2024, and will remain an industry advisor to EQT and the largest individual investor in Parexel.
Quick answer
Parexel Appoints Peyton Howell as Chief Executive Officer (CEO) to Succeed Jamie Macdonald (March 18, 2024). Parexel is based in Durham, North Carolina, United States.
- Who is the new Chief Executive Officer at Parexel?
- Parexel named Peyton Howell Chief Executive Officer, announced March 18, 2024.
- What did Parexel announce on March 18, 2024?
- Parexel announced that Chief Operating and Growth Officer Peyton Howell will succeed Jamie Macdonald as Chief Executive Officer (CEO) effective May 15, 2024, while also being appointed to the company’s Board of Directors on the same date. Jamie Macdonald will continue on the Board through Dec. 31, 2024, and will remain an industry advisor to EQT and the largest individual investor in Parexel.
- What does Parexel do?
- Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster.
- Where is Parexel based?
- Parexel is based in Durham, North Carolina, United States.
- Which similar companies made leadership changes around the same time?
- Arcutis (March 11, 2024), BioMarin Pharmaceutical (March 8, 2024), TransCode Therapeutics (March 28, 2024) and Vast Therapeutics (March 8, 2024) also announced leadership changes within 45 days of Parexel.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Arcutis Promotes Todd Tucker to Senior VP and Chief Human Resources Officer (March 11, 2024)
- BioMarin Appoints Cristin Hubbard as Chief Commercial Officer (March 8, 2024)
- TransCode Therapeutics Appoints Daniel Vlock, M.D. as Chief Medical Officer (March 28, 2024)
- Vast Therapeutics Appoints Paul Bruinenberg as Chief Medical Officer and Chris Polage as Medical Director (March 8, 2024)
- MBrace Appoints Steve Alley, Ph.D., as Chief Scientific Officer (March 5, 2024)
- Aculys Pharma Appoints Hidemasa Tanigaki as Chief Executive Officer and Representative Director (April 1, 2024)
Who to call at Parexel, and when
A new leader at Parexel brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Parexel raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Parexel, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Parexel. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Parexel changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Parexel changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.